EXPLORE A TOPIC
Research and resources to help you take a closer look.
The resource library
40 resourcesThe rat wound-chamber model is a controlled in vivo system for quantifying extracellular matrix accumulation and tissue repair processes in response to GHK-Cu. This article explains the methodology, measured endpoints, and limitations of this model, focusing on evidence from a key cited study.
This resource explains how to critically assess peptide studies conducted in cell lines, highlighting key terminology, experimental models, endpoints, and the limitations of extrapolating findings beyond in vitro systems. Evidence from recent studies is used to illustrate best practices and common pitfalls.
Semax oxidative-stress research employs multiple experimental readouts to robustly characterize its effects on reactive oxygen species (ROS) production, metal chelation, and cytotoxicity. This article explains the rationale for such assay design, details the specific endpoints used in a recent in-vitro and cell-based study, and discusses the strengths and limitations of this approach for peptide research interpretation.
A detailed analysis of the 2017 Selank study in IMR-32 neuroblastoma cells, focusing on the interpretation of its null gene-expression results, the experimental context, and the implications for peptide research.
Gastric-emptying and growth-hormone endpoints in ipamorelin research reflect distinct physiological processes and experimental aims. This resource reviews the mechanistic basis, experimental models, and interpretive limitations of each endpoint, drawing on controlled animal studies.
A technical review of how experimental models and biological matrices influence TB-500 peptide analysis, metabolism, and interpretation of research findings. Distinguishes in-vitro, animal, and sample-specific results, highlighting methodological limitations and the importance of context in peptide research.
This resource explains how scientifically literate readers should interpret uncontrolled human observations in BPC-157 research, distinguishing anecdotal findings from rigorous evidence. It reviews the current state of published research, clarifies terminology, and provides a checklist for critical appraisal, with explicit attention to evidence limitations and the gap between preclinical and clinical data.
Peptide sequence modifications—such as amino acid substitutions, cyclization, and backbone alterations—profoundly impact research interpretation. This article explores how these changes affect experimental outcomes, mechanistic understanding, and the translation of findings, drawing on current evidence and highlighting key limitations.
Gene-expression changes and collagen accumulation are distinct endpoints in GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) research. This article examines why gene expression data do not directly equate to measurable collagen deposition, drawing on in vitro, animal, and gene array studies. Evidence limitations and mechanistic uncertainties are discussed.
Copper-binding measurements in the Semax laboratory study provide mechanistic insight into how Semax interacts with copper ions and modulates copper-catalyzed oxidative processes in vitro. These measurements clarify Semax’s ability to chelate copper, disrupt copper-amyloid beta complexes, and reduce reactive oxygen species (ROS) production, but findings are limited to controlled laboratory settings and do not establish clinical efficacy or safety.
This resource examines the immune-cell pathways discussed in the thymosin alpha-1 literature review, distinguishing supported mechanisms from hypotheses. It details in-vitro, animal, and human evidence, clarifies methodological limitations, and highlights unresolved questions in the field.
A detailed review of the IMR-32 neuroblastoma cell study examining Selank alone and in combination with GABA, focusing on gene expression changes in the GABAergic system. Evidence is limited to in vitro findings and does not imply clinical effects.
